Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hiraku Yanada
Observed name:
H. Yanada
Institution:
Asahikawa Medical University
Observed institution:
Asahikawa Medical University
ORCID:
0009-0009-9915-554X
Observed ORCID:
0009-0009-9915-554X
OpenAlex ID:
A5017427033
Viability and diagnostic potential of tissues obtained through cryobiopsy
2024
·
Ryotaro Kida
, Ryohei Yoshida
, et al.
·
Respiratory Investigation
·
5
Sotorasib resistance in KRAS G12C-mutant invasive mucinous adenocarcinoma with implications for VEGF-A
2025
·
Hiraku Yanada
, Ryohei Yoshida
, et al.
·
npj Precision Oncology
·
4
PDF
Case Report: Case series: association between blood concentration and side effects of sotorasib
2023
·
Ryota Shigaki
, Ryohei Yoshida
, et al.
·
Frontiers in Oncology
·
2
Real-World Treatment Outcomes in the First and Subsequent Coronavirus Disease 2019 (COVID-19) Hospital Clusters
2025
·
Yoshinobu Ohsaki
, Takaaki Sasaki
, et al.
·
Cureus
·
1
PDF
Monitoring SARS-CoV-2 Viral Load and CD4+ T-cell Count After ART in a Patient Diagnosed With AIDS Following SARS-CoV-2 Infection: A Case Report
2023
·
Yasuhiro Umekage
, Mayumi Hatayama
, et al.
·
Cureus
·
1
PDF
Does the natural course of COVID‐19 infection include radiographic cystic changes?
2022
·
Noriko Hirai
, Ryotaro Kida
, et al.
·
Clinical Case Reports
·
1
Thymic Carcinoma with Treatment-Related Leukemia Showing Complete Response to Bcl-2 Inhibitors and 5-azacytidine: A Case Report
2026
·
Kiichi Nitanai
, Takeshi Saito
, et al.
·
JTO Clinical and Research Reports
Understanding nosocomial influenza transmission in acute-care and chronic-care wards using an agent-based model
2026
·
Yasuhiro Umekage
, Takashi Watanabe
, et al.
·
Journal of Hospital Infection
PDF
Abstract 4324: Dipeptidyl peptidase 4 restoration facilitates anti-tumor immunity in KRAS-LKB1-mutant lung cancer
2026
·
Hiraku Yanada
·
Cancer Research
Invasive Fungal Infection Requiring Dif ferential Diagnosis from Miliary Tuberculosis Based on Imaging: Utility of Genetic and Ultrastructural Analyses from FFPE Tissues
2026
·
Yuki Kamikokura
, Masanori Goto
, et al.
·
Medical Mycology Journal
PDF
Data from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025
·
Toshiyuki Tenma
, Ryohei Yoshida
, et al.
Figure 1 from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025
·
Toshiyuki Tenma
, Ryohei Yoshida
, et al.
Figure 2 from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025
·
Toshiyuki Tenma
, Ryohei Yoshida
, et al.
Table S1 from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025
·
Toshiyuki Tenma
, Ryohei Yoshida
, et al.
Figure S1 from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025
·
Toshiyuki Tenma
, Ryohei Yoshida
, et al.
Figure S4 from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025
·
Toshiyuki Tenma
, Ryohei Yoshida
, et al.
Figure 4 from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025
·
Toshiyuki Tenma
, Ryohei Yoshida
, et al.
Figure S3 from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025
·
Toshiyuki Tenma
, Ryohei Yoshida
, et al.
Figure S2 from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025
·
Toshiyuki Tenma
, Ryohei Yoshida
, et al.
Figure 3 from Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025
·
Toshiyuki Tenma
, Ryohei Yoshida
, et al.
Dipeptidyl Peptidase 4 Restoration Facilitates Antitumor Immunity in KRAS-LKB1–Mutant Lung Cancer
2025
·
Toshiyuki Tenma
, Ryohei Yoshida
, et al.
·
Cancer Research Communications
Treatment of lung adenocarcinoma with chemotherapy helps mitigate chronic myeloid leukaemia progression: A case report
2024
·
Kazunori Nagasue
, Ryotaro Kida
, et al.
·
Oncology Letters
PDF
EP.03C.03 Development of a Novel Immunotherapy for ICI Resistant KRAS-Mutantlung Cancer
2024
·
T. Tenma
, K. Nitanai
, et al.
·
Journal of Thoracic Oncology
PDF
Show more works
View as search
Works count:
23
Citation count:
14
H-index:
2
I10-index:
Year
Topic
Type